EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Gastric Adenocarcinoma with Enteroblastic Differentiation

Ádám Ferenczi, Levente Kuthi, Anita Sejben

Pathobiology · 07.01.2025 · 92 (3) · 169-179

DOI: 10.1159/000543330 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathobiology, online erschienen am 07.01.2025. Verfasst von Ádám Ferenczi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastric adenocarcinoma with enteroblastic differentiation (GAED) is a rare entity with worse prognosis compared to conventional gastric adenocarcinomas. Its histological characteristics are fetal gut-like architecture and tumor cells with cytoplasmic clearing, as well as positive immunohistochemical reaction to at least one of the enteroblastic markers. Hereby, we present a case of GAED with neuroendocrine marker positivity, with whole-exome sequencing (WES), and an updated literature review. Case Presentation: A 68-year-old woman presented at the general practitioner with abdominal pain. Abdominal ultrasound described gastric wall thickening raising suspicion of gastric cancer; thus, gastroscopy was performed, and biopsy samples were taken, which confirmed malignancy. Neoadjuvant systemic chemotherapy was initiated, and total gastrectomy was performed. Microscopically, pleomorphic polygonal cells were visible with clear cytoplasm and high-grade cellular atypia. Alcian blue and PAS stains demonstrated positivity for acidic and neutral mucins. P53 IHC was negative, indicative of null-phenotype, while Syntaxin-1 and Chromogranin showed focal positivity. SALL4 and Glypican 3 were positive; however, AFP displayed only minimal, uncertain positivity. The Ki67 labeling index was 70%. Due to the morphological and immunohistochemical characteristics, the tumor was concluded as GAED with neuroendocrine marker positivity. WES was carried out revealing 4 pathogenic, including TP53, KLHL7, RAPSN, and ACTA1, and 3 likely pathogenic mutations, encompassing PNKP, HNF1A, and ADNP.

Discussion

GAED is a rare subtype of gastric adenocarcinomas, representing 0.3–5.4% of all cases, and has an unclarified etiology. Our WES results identified new pathogenic and likely pathogenic mutations. From a differential diagnostic point of view, hepatoid adenocarcinoma and the possibility of metastatic origin have to be excluded.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaHumansFemaleAgedBiomarkers, TumorExome SequencingCell DifferentiationGastrectomyImmunohistochemistry

Stichwörter der Autor:innen

Gastric adenocarcinoma with enteroblastic differentiationNeuroendocrine marker expressionWhole-exome sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, University of Szeged, Szeged, Hungary.
  • Department of Surgical and Molecular Pathology, National Institute of Oncology, Budapest, Hungary.
  • Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.

Zitieren

APA

Ferenczi, Á., Kuthi, L., & Sejben, A. (2025). Gastric Adenocarcinoma with Enteroblastic Differentiation. Pathobiology, 92(3), 169-179. https://doi.org/10.1159/000543330

Vancouver

Ferenczi Á, Kuthi L, Sejben A. Gastric Adenocarcinoma with Enteroblastic Differentiation. Pathobiology. 2025;92(3):169-179. doi:10.1159/000543330

BibTeX
@article{Ferenczi2025,
  author = {Ferenczi, Ádám and Kuthi, Levente and Sejben, Anita},
  title = {Gastric Adenocarcinoma with Enteroblastic Differentiation},
  journal = {Pathobiology},
  year = {2025},
  volume = {92},
  number = {3},
  pages = {169--179},
  doi = {10.1159/000543330}
}
Kostenlos starten →